PRQR · ProQR Therapeutics N.V.

Summary

ProQR Therapeutics N.V. announced it will host a virtual Investor and Analyst Event on April 8, 2026, titled 'Expanding the Axiomer™ RNA Editing Opportunity Beyond AX-0810,' to showcase its broader RNA editing pipeline, announce new programs with clinical data readouts, and unveil the primary indication for AX-0810 ahead of anticipated target engagement data in H1 2026.

Key takeaways

• Event date and time: April 8, 2026, 10:00 am ET to approximately 11:30 am ET
• Virtual format: Webcast presentations and Q&A with analysts and management
• Registration: https://lifescievents.com/event/g09gufqylu/
• Will announce new programs with clinical data readouts and primary indication for AX-0810
• Precedes AX-0810 target engagement data expected in H1 2026